RxDoctor Payments Data

Danny Kaup, MD

Emergency Medicine · Valparaiso, INNPI 1851370050

Payments from drug & device makers

$379in general payments, 2019–2025

Across 23 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$85
  • Pfizer$72
  • Biohaven Pharmaceutical Holding Company Ltd.$39
  • Johnson & Johnson$28
  • Sanofi Pasteur Inc.$28
  • Idorsia Pharmaceuticals US Inc$28
  • plus $98 from 5 others

What the payments were for

  • Food & beverage$379100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$379 in reported general payments places this provider in the 90th percentile of 1,073 emergency medicine providers in Indiana.

See all emergency medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$167,294
Medicare patients
805
Services billed
2,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide100$129,151
JardianceEmpagliflozin73$109,185
EliquisApixaban73$73,918
MounjaroTirzepatide20$29,030
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$26,881
KerendiaFinerenone15$23,235
TrulicityDulaglutide12$22,105
XareltoRivaroxaban16$16,086
JanuviaSitagliptin Phosphate23$15,630
FarxigaDapagliflozin Propanediol15$13,202
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$7,476
Breo ElliptaFluticasone/Vilanterol12$7,316
Icosapent Ethyl15$6,249
LantusInsulin Glargine,hum.Rec.Anlog13$3,858
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$3,719

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$72$73,91873 claims
Lilly USA, LLCMounjaro, Trulicity$27$51,13532 claims
BayerKerendia$85$23,23515 claims
Johnson & JohnsonXarelto$28$16,08616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,073 emergency medicine providers in Indiana.

Other emergency medicine in Valparaiso

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →